Medical Benefits First-of-its-kind psilocybin trial approved in Vancouver November 4, 2022 / May 1, 2026 by Marcus A Vancouver-based pharmaceutical company will run the first take home psilocybin clinical trial in North America. Health Canada has approved phase two of the trial by Apex Labs, which will evaluate the safety and efficacy of its low dose, multi-dose product APEX-52 in treating depression in veterans with post-traumatic stress disorder. Veterans Affairs Canada estimates up […] Read more » Mental Health psilocybin psilocybin trial Vancouver